Ozone impairs endogenous compensatory responses in allergic asthma.

Asthma is a chronic inflammatory airway disease characterized by acute exacerbations triggered by inhaled allergens, respiratory infections, or air pollution. Ozone (O), a major component of air pollution, can damage the lung epithelium in healthy individuals. Despite this association, little is known about the effects of O and its impact on chronic lung disease. Epidemiological data have demonstrated that elevations in ambient O are associated with increased asthma exacerbations. To identify mechanisms by which O exposure leads to asthma exacerbations, we developed a two-hit mouse model where mice were sensitized and challenged with three common allergens (dust mite, ragweed and Aspergillus fumigates, DRA) to induce allergic inflammation prior to exposure to O (DRAO). Changes in lung physiology, inflammatory cells, and inflammation were measured. Exposure to O following DRA significantly increased airway hyperreactivity (AHR), which was independent of TLR4. DRA exposure resulted in increased BAL eosinophilia while O exposure resulted in neutrophilia. Additionally, O exposure following DRA blunted anti-inflammatory and antioxidant responses. Finally, there were significantly less monocytes and innate lymphoid type 2 cells (ILC2s) in the dual challenged DRA-O group suggesting that the lack of these immune cells may influence O-induced AHR in the setting of allergic inflammation. In summary, we developed a mouse model that mirrors some aspects of the clinical course of asthma exacerbations due to air pollution and identified that O exposure in the asthmatic lung leads to impaired endogenous anti-inflammatory and antioxidant responses and alterations inflammatory cell populations.